Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accelerating Antibiotics: Kevin Outterson And Joe Larsen Explain CARB-X

Executive Summary

Podcast with CARB-X Executive Director Kevin Outterson and BARDA Acting Deputy Director Joe Larsen describes the work of the accelerator, which just announced the first eleven projects in its portfolio.

Advertisement

Related Content

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics
AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)
AMR Roundtable Part 1: Incentives Spur Antimicrobial Investments, But More Needed

Topics

Advertisement
UsernamePublicRestriction

Register

PS120349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel